Detalhe da pesquisa
1.
Intratumoral injection of the seasonal flu shot converts immunologically cold tumors to hot and serves as an immunotherapy for cancer.
Proc Natl Acad Sci U S A
; 117(2): 1119-1128, 2020 01 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-31888983
2.
Memory Precursors and Short-Lived Effector T cell Subsets Have Different Sensitivities to TGFß.
Int J Mol Sci
; 24(4)2023 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36835342
3.
Low-dose interleukin-2 impairs host anti-tumor immunity and inhibits therapeutic responses in a mouse model of melanoma.
Cancer Immunol Immunother
; 66(1): 9-16, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27757560
4.
CD8(+) T cells sabotage their own memory potential through IFN-γ-dependent modification of the IL-12/IL-15 receptor α axis on dendritic cells.
J Immunol
; 188(8): 3639-47, 2012 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22430740
5.
Inhibition of MALT1 and BCL2 induces synergistic anti-tumor activity in models of B cell lymphoma.
Mol Cancer Ther
; 2024 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38507740
6.
Development of tumor-infiltrating CD8+ T cell memory precursor effector cells and antimelanoma memory responses are the result of vaccination and TGF-ß blockade during the perioperative period of tumor resection.
J Immunol
; 186(6): 3309-16, 2011 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21289306
7.
NKG2D signaling shifts the balance of CD8 T cells from single cytokine- to polycytokine-producing effector cells.
Mol Immunol
; 155: 1-6, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36634520
8.
Gut Microbial Shifts Indicate Melanoma Presence and Bacterial Interactions in a Murine Model.
Diagnostics (Basel)
; 12(4)2022 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35454006
9.
Priming with very low-affinity peptide ligands gives rise to CD8(+) T-cell effectors with enhanced function but with greater susceptibility to transforming growth factor (TGF)ß-mediated suppression.
Cancer Immunol Immunother
; 60(11): 1543-51, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21681376
10.
CD8 co-receptor promotes susceptibility of CD8+ T cells to transforming growth factor-ß (TGF-ß)-mediated suppression.
Cancer Immunol Immunother
; 60(2): 291-7, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21193909
11.
Venetoclax Increases Intratumoral Effector T Cells and Antitumor Efficacy in Combination with Immune Checkpoint Blockade.
Cancer Discov
; 11(1): 68-79, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32887697
12.
Oncolytic Viruses-Natural and Genetically Engineered Cancer Immunotherapies.
Front Oncol
; 7: 202, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28955655
13.
Molecular Pathways: Mechanism of Action for Talimogene Laherparepvec, a New Oncolytic Virus Immunotherapy.
Clin Cancer Res
; 22(5): 1048-54, 2016 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26719429
14.
Oncolytic viruses: a new class of immunotherapy drugs.
Nat Rev Drug Discov
; 15(9): 660, 2016 08 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-30907381
15.
Non-oncogenic Acute Viral Infections Disrupt Anti-cancer Responses and Lead to Accelerated Cancer-Specific Host Death.
Cell Rep
; 17(4): 957-965, 2016 10 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-27760326
16.
Oncolytic viruses: a new class of immunotherapy drugs.
Nat Rev Drug Discov
; 14(9): 642-62, 2015 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-26323545
17.
Enhancing the Magnitude of Antibody Responses through Biomaterial Stereochemistry.
ACS Biomater Sci Eng
; 1(7): 601-609, 2015 Jul 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33434976
18.
NK cells and CD8+ T cells cooperate to improve therapeutic responses in melanoma treated with interleukin-2 (IL-2) and CTLA-4 blockade.
J Immunother Cancer
; 3: 18, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25992289
19.
CD95 and CD95L promote and protect cancer stem cells.
Nat Commun
; 5: 5238, 2014 Nov 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-25366259
20.
Antigenic peptide nanofibers elicit adjuvant-free CD8⺠T cell responses.
Vaccine
; 32(10): 1174-80, 2014 Feb 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-24308959